Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.00427 | uM | 5911.09 | 1.0063 | 1.0114 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.0213 | uM | 5911.09 | 1.0094 | 1.0169 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.107 | uM | 5911.09 | 0.9533 | 0.9154 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.533 | uM | 5911.09 | 1.0033 | 1.0059 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 2.67 | uM | 5911.09 | 0.9433 | 0.8973 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 13.3 | uM | 5911.09 | 0.9308 | 0.8745 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 66.7 | uM | 5911.09 | 0.8607 | 0.7465 | 1.1067 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.000171 | uM | 5912.091 | 1.0238 | 1.0435 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.000853 | uM | 5912.091 | 1.0518 | 1.0947 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.00427 | uM | 5912.091 | 1.0422 | 1.0771 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.0213 | uM | 5912.091 | 1.0702 | 1.1282 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.107 | uM | 5912.091 | 0.9991 | 0.9983 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 0.533 | uM | 5912.091 | 1.0697 | 1.1274 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 2.67 | uM | 5912.091 | 1.0311 | 1.0568 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 13.3 | uM | 5912.091 | 1.0712 | 1.1300 | 1.0917 | |
| CAMA-1 | HR+ | Luminal | Erlotinib | EGFR | ErbB | 66.7 | uM | 5912.091 | 0.9633 | 0.9326 | 1.0917 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000171 | uM | 7429.09 | 1.0206 | 1.0183 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.000853 | uM | 7429.09 | 1.0199 | 1.0176 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.00427 | uM | 7429.09 | 1.0159 | 1.0141 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.0213 | uM | 7429.09 | 1.0008 | 1.0007 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.107 | uM | 7429.09 | 0.9858 | 0.9873 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 0.533 | uM | 7429.09 | 1.0153 | 1.0136 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 2.67 | uM | 7429.09 | 1.0132 | 1.0117 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 13.3 | uM | 7429.09 | 1.0002 | 1.0002 | 2.2456 | |
| HBL-100 | Unknown | Unknown | Erlotinib | EGFR | ErbB | 66.7 | uM | 7429.09 | 0.9289 | 0.9353 | 2.2456 |